Buenos Aires, Argentina - From August 2 to August 4, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") attended the Society of Latin American Cardiology Intervention 2017 ("SOLACI 2017") with thousands of cardiovascular interventional experts from South America and other regions in attendance. MicroPort® displayed its third-generation drug-eluting stent Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®") and broadcasted a high-risk live case in which Firehawk® was used to treat bifurcation lesion.
On August 3, a live case of using Firehawk® to treat bifurcation lesion in left main coronary artery was broadcasted during the congress. The case was performed by a renowned UK expert Dr. Andreas Baumbach with the assistance of two experts from Instituto Cardiovascular de Buenos Aires. Dr. Andreas Baumbach adopted mini crush, successfully implanted two Firehawk® stents (3.5*13mm and 3.5*23mm), and then used proximal optimisation technique to post-dilate. The operation achieved successful outcome and there is no malapposition with Firehawk®. As a demonstration case, Dr. Andreas Baumbach fully presented the operative strategies as well as tips and tricks in the bifurcation lesion operation. He spoke highly of Firehawk®'s excellent crossability, and shared the three-month Optical Computerized Tomography ("OCT") data from the TARGET All Comer trial, the first post-market large-scale, randomized trial in Europe for Firehawk®. The outstanding performance of Firehawk® won high recognition from experts in attendance.
During the SOLACI 2017, MicroPort® booth attracted wide attention from the attendees. Dr. Ricardo Lluveras, Chairman of SOLACI, and Dr. Jose Luis Leiva Pons, Chairman-elect of SOLACI, also visited MicroPort® booth and exchanged ideas with Jonathan Chen, MicroPort® Executive Vice President of International Operations and Investor Relations, and Dr. Linda Lin, First Vice President of MicroPort® International Business. The SOLACI 2017 provided a platform for attendees to gain deeper understanding in Firehawk®'s excellent performance and growth potential, paving the way for MicroPort® to further expand the South American market.